Publicaciones en colaboración con investigadores/as de University of Copenhagen (21)

2023

  1. Correction to: The power of genetic diversity in genome-wide association studies of lipids (Nature, (2021), 600, 7890, (675-679), 10.1038/s41586-021-04064-3)

    Nature

  2. Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans

    Frontiers in Endocrinology, Vol. 14

2022

  1. A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids

    American Journal of Human Genetics, Vol. 109, Núm. 8, pp. 1366-1387

  2. A polygenic risk score for multiple myeloma risk prediction

    European Journal of Human Genetics, Vol. 30, Núm. 4, pp. 474-479

  3. A saturated map of common genetic variants associated with human height

    Nature, Vol. 610, Núm. 7933, pp. 704-712

  4. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 31, Núm. 9, pp. 1863-1866

  5. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

    Genome Biology, Vol. 23, Núm. 1

2021

  1. Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival

    International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894

  2. The power of genetic diversity in genome-wide association studies of lipids

    Nature, Vol. 600, Núm. 7890, pp. 675-679

  3. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

    Frontiers in Immunology, Vol. 12

2020

  1. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

    Pharmacogenomics Journal

  2. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

  3. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96

2018

  1. Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

    British Journal of Haematology, Vol. 183, Núm. 3, pp. 375-384

2017

  1. Identification of miRSNPs associated with the risk of multiple myeloma

    International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534

2015

  1. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

    Nature Communications, Vol. 6

  2. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E351-E358

  3. Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium

    Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559

2014

  1. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations - An extensive replication of the associations from the candidate gene era

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 4, pp. 670-674